Edit Symbol List
SIAL: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 60.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 780,899 |
| Previous Close | $ 53.88 |
| 52 Wk High / Low | $ 56.29 / $ 31.4518 |
| Shares Outstanding | 121,814,000 |
| Market Value | $ 6,570,647,160 |
| P/E Ratio | 19.69 |
| Forward P/E (1yr) | 17.21 |
| Earnings Per Share | $ 2.74 |
| Annualized Dividend | $ 0.58 |
| Ex Dividend Date | Aug. 28, 2009 |
| Dividend Payment Date | Sep. 15, 2009 |
| Current Yield | 1.08 % |
| Beta | 1.05 |
| NASDAQ Official Open Price: | $ 53.49 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 53.94 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About SIAL?
Ask your question about about Sigma-Aldrich Corporation (SIAL) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Sigma-Aldrich Corporation (“the Company”) was incorporated under the laws of the State of Delaware in May 1975. Effective July 31, 1975 (“Reorganization”), the Company succeeded, as a reporting company, Sigma International, Ltd., the predecessor of Sigma Chemical Company (“Sigma”), and Aldrich Chemical Company, Inc. (“Aldrich”), both of which had operated continuously for more than 20 years prior to the Reorganization. The Company’s principal executive offices are located at 3050 Spruce Street, St. Louis, Missouri, 63103. On February 28, 2005, the Company completed its acquisition of all of the outstanding capital securities of JRH Biosciences Pty Ltd., CSL US Inc. and JRH Biosciences Limited, which collectively comprised the JRH Biosciences division (JRH) of CSL Limited for $366.8 million. JRH is a leading global supplier of cell culture and sera products to the biopharmaceutical industry. ... More ...
Links to all Sigma-Aldrich Corporation (SIAL) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Consensus Recommendation |
|
|
Analyst Info |
|
| Annual EPS Est: | $ 2.77 |
| Quarterly EPS Est: | $ 0.72 |
| PEG Ratio: | 1.93 |
| Mean Recommendation: View Summary/View All |
2.56 |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
0.11%
